Wu LH - Search Results

1

Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma.

King KL, Hwang JJ, Chau GY, Tsay SH, Chi CW, Lee TG, Wu LH, Wu CW, Lui WY. King KL, et al. Among authors: wu cw, wu lh. J Gastroenterol Hepatol. 1998 Mar;13(3):273-9. doi: 10.1111/j.1440-1746.1998.01555.x. J Gastroenterol Hepatol. 1998. PMID: 9570240

2

Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.

P'eng FK, Lui WY, Chang TJ, Kao HL, Wu LH, Liu TY, Chi CW. P'eng FK, et al. Among authors: wu lh. Cancer. 1988 Nov 15;62(10):2134-8. doi: 10.1002/1097-0142(19881115)62:10<2134::aid-cncr2820621012>3.0.co;2-y. Cancer. 1988. PMID: 2460210

3

Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?

Chiu JH, Wu LH, Kao HL, Chang HM, Tsay SH, Loong CC, Chau GY, Lui WY. Chiu JH, et al. Among authors: wu lh. Hepatology. 1993 Jul;18(1):96-102. Hepatology. 1993. PMID: 8392030

4

Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution.

Chiu JH, Chang HM, Kao HL, Wu LH, Lui WY. Chiu JH, et al. Among authors: wu lh. Cancer Detect Prev. 1996;20(1):43-51. Cancer Detect Prev. 1996. PMID: 8907202

5

Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity.

Chiu JH, Lui WY, Chang HM, Loong CC, Wu LH, Kao HL, Wu CW. Chiu JH, et al. Among authors: wu cw, wu lh. Cytometry. 1997 Dec 15;30(6):317-23. Cytometry. 1997. PMID: 9440824

6

Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.

Shyr YM, Su CH, Wu LH, Li AF, Chiu JH, Wu CW, Lui WY. Shyr YM, et al. Among authors: wu cw, wu lh. Ann Surg. 1999 Apr;229(4):523-7. doi: 10.1097/00000658-199904000-00011. Ann Surg. 1999. PMID: 10203085 Free PMC article.

7

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma.

Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH, King KL, Loong CC, Hsia CY, Chi CW. Chau GY, et al. Among authors: wu cw, wu lh. Ann Surg. 2000 Apr;231(4):552-8. doi: 10.1097/00000658-200004000-00015. Ann Surg. 2000. PMID: 10749617 Free PMC article.

8

Malignant solid and pseudopapillary tumor of the pancreas--clinicohistological, immunohistochemical, and flow cytometric evaluation.

Lai HW, Su CH, Li AF, Wu LH, Shyr YM, Chen TH, Wu CW, Lui WY. Lai HW, et al. Among authors: wu cw, wu lh. Hepatogastroenterology. 2006 Mar-Apr;53(68):291-5. Hepatogastroenterology. 2006. PMID: 16608042

9

Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry.

Chiu JH, Kao HL, Wu LH, Chang HM, Lui WY. Chiu JH, et al. Among authors: wu lh. J Clin Invest. 1992 Feb;89(2):539-45. doi: 10.1172/JCI115618. J Clin Invest. 1992. PMID: 1310697 Free PMC article.

10

DNA ploidy as a major prognostic factor in resectable ampulla of Vater cancers.

Shyr YM, Su CH, Wu LH, Li AF, Chiu JH, Lui WY. Shyr YM, et al. Among authors: wu lh. J Surg Oncol. 1993 Aug;53(4):220-5. doi: 10.1002/jso.2930530406. J Surg Oncol. 1993. PMID: 8101889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters